Progressive oxidation of cytoskeletal proteins and accumulation of denatured hemoglobin in stored red cells.
Red blood cell (RBC) membrane proteins undergo progressive pathological alterations during storage. In conditions of increased cellular stress, the cytoskeleton also sustains certain modifications. The hemoglobin (Hb) content and oxidative status of the RBC cytoskeletons as a function of the storage period remain unclear. The possible Hb content and oxidative alterations occurring in the cytoskeletons in the course of storage were monitored in six units, by means of electrophoresis, immunoblotting and protein carbonylation assays. A proportion of the ghost-bound Hb consists of non-reducible crosslinkings of probably oxidized(denatured Hb or hemichromes. The defective Hb-membrane association was strongly affected by the prolonged storage. A progressive accumulation of Hb monomers, multimers and high molecular weight aggregates to corresponding cytoskeletons were also evident. The oxidative index of the cytoskeletal proteins was found increased, signalizing oxidative modifications in spectrin and possibly other cytoskeletal proteins. The reported data corroborate the evidence for oxidative damage in membrane proteins with emphasis to the cytoskeletal components. They partially address the pathophysiological mechanisms underlying the RBC storage lesion, add some new insight in the field of RBC storage as a hemoglobin- and cytoskeleton-associated pathology and suggest the possible use of antioxidants in the units intended for transfusion.
Kriebardis
Anastasios G
AG
Department of Cell Biology and Biophysics, Faculty of Biology, University of Athens, Panepistimiopolis, Athens, Greece.
Antonelou
Marianna H
MH
Stamoulis
Konstantinos E
KE
Economou-Petersen
Effrosini
E
Margaritis
Lukas H
LH
Papassideri
Issidora S
IS
D000225:Adenine / Q000494:pharmacology*; D001782:Blood Donors; D001793:Blood Preservation; D002951:Citrates / Q000494:pharmacology*; D003451:Cryoprotective Agents / Q000494:pharmacology*; D003598:Cytoskeletal Proteins / Q000378:metabolism* / Q000502:physiology; D004586:Electrophoresis; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000378:metabolism; D004912:Erythrocytes / Q000187:drug effects* / Q000378:metabolism; D005947:Glucose / Q000494:pharmacology*; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D007038:Hypotonic Solutions / Q000494:pharmacology; D015151:Immunoblotting; D010084:Oxidation-Reduction; D010710:Phosphates / Q000494:pharmacology*; D050050:Protein Carbonylation
C034876:CPDA solutions; D002951:Citrates; D003451:Cryoprotective Agents; D003598:Cytoskeletal Proteins; D006454:Hemoglobins; D007038:Hypotonic Solutions; D010710:Phosphates; D005947:Glucose; D000225:Adenine